Coenzyme Q10 supplementation in aging and disease

Frontiers in Physiology

Volumn 9, Issue FEB, 2018, Pages

  Hernández Camacho, Juan D ^a   Bernier, Michel ^b   López Lluch, Guillermo ^a   Navas, Plácido ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Aging; Antioxidant; Coenzyme Q; CoQ deficiency; Disease; Mitochondria

Indexed keywords

UBIDECARENONE;

AGING; ANTIOXIDANT ACTIVITY; BIOENERGY; BIOSYNTHESIS; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; DEGENERATIVE DISEASE; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; FEMALE INFERTILITY; HEART FAILURE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INFERTILITY; INFLAMMATION; KIDNEY DISEASE; MALE INFERTILITY; METABOLIC SYNDROME X; NONHUMAN; REVIEW; SUPPLEMENTATION; TREATMENT OUTCOME; UBIDECARENONE DEFICIENCY SYNDROME;

EID: 85041849954     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2018.00044     Document Type: Review

References (126)

1. Abdollahzad, H., Aghdashi, M. A., Asghari Jafarabadi, M., and Alipour, B. (2015). Effects of coenzyme Q10 supplementation on inflammatory cytokines (TNF-alpha, IL-6) and oxidative stress in rheumatoid arthritis patients: a randomized controlled trial. Arch. Med. Res. 46, 527-533. doi: 10.1016/j.arcmed.2015.08.006
2. Acosta, M. J., Vazquez Fonseca, L., Desbats, M. A., Cerqua, C., Zordan, R., Trevisson, E., et al. (2016). Coenzyme Q biosynthesis in health and disease. Biochim. Biophys. Acta 1857, 1079-1085. doi: 10.1016/j.bbabio.2016.03.036
3. Alcazar-Fabra, M., Navas, P., and Brea-Calvo, G. (2016). Coenzyme Q biosynthesis and its role in the respiratory chain structure. Biochim. Biophys. Acta 1857, 1073-1078. doi: 10.1016/j.bbabio.2016.03.010
4. Alehagen, U., Aaseth, J., and Johansson, P. (2015). Reduced cardiovascular mortality 10 years after supplementation with selenium and coenzyme Q10 for four years: follow-up results of a prospective randomized double-blind placebo-controlled trial in elderly citizens. PLoS ONE 10:e0141641. doi: 10.1371/journal.pone.0141641
5. Alehagen, U., Alexander, J., and Aaseth, J. (2016). Supplementation with selenium and coenzyme Q10 reduces cardiovascular mortality in elderly with low selenium status. A secondary analysis of a randomised clinical trial. PLoS ONE 11:e0157541. doi: 10.1371/journal.pone.0157541
6. Alehagen, U., Johansson, P., Aaseth, J., Alexander, J., and Brismar, K. (2017). Increase in insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 1 after supplementation with selenium and coenzyme Q10. A prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens. PLoS ONE 12:e0178614. doi: 10.1371/journal.pone.0178614
7. Allan, C. M., Awad, A. M., Johnson, J. S., Shirasaki, D. I., Wang, C., Blaby-Haas, C. E., et al. (2015). Identification of Coq11, a new coenzyme Q biosynthetic protein in the CoQ-synthome in Saccharomyces cerevisiae. J. Biol. Chem. 290, 7517-7534. doi: 10.1074/jbc.M114.633131
8. Arcaniolo, D., Favilla, V., Tiscione, D., Pisano, F., Bozzini, G., Creta, M., et al. (2014). Is there a place for nutritional supplements in the treatment of idiopathic male infertility? Arch. Ital. Urol. Androl. 86, 164-170. doi: 10.4081/aiua.2014.3.164
9. Arun, S., Liu, L., and Donmez, G. (2016). Mitochondrial biology and neurological diseases. Curr. Neuropharmacol. 14, 143-154. doi: 10.2174/1570159X13666150703154541
10. Asencio, C., Rodriguez-Hernandez, M. A., Briones, P., Montoya, J., Cortes, A., Emperador, S., et al. (2016). Severe encephalopathy associated to pyruvate dehydrogenase mutations and unbalanced coenzyme Q10 content. Eur. J. Hum. Genet. 24, 367-372. doi: 10.1038/ejhg.2015.112
11. Ashraf, S., Gee, H. Y., Woerner, S., Xie, L. X., Vega-Warner, V., Lovric, S., et al. (2013). ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J. Clin. Invest. 123, 5179-5189. doi: 10.1172/JCI69000
12. Barca, E., Musumeci, O., Montagnese, F., Marino, S., Granata, F., Nunnari, D., et al. (2016). Cerebellar ataxia and severe muscle CoQ10 deficiency in a patient with a novel mutation in ADCK3. Clin. Genet. 90, 156-160. doi: 10.1111/cge.12742
13. Battino, M., Gorini, A., Villa, R. F., Genova, M. L., Bovina, C., Sassi, S., et al. (1995). Coenzyme Q content in synaptic and non-synaptic mitochondria from different brain regions in the ageing rat. Mech. Ageing Dev. 78, 173-187. doi: 10.1016/0047-6374(94)01535-T
14. Beal, M. F. (2002). Coenzyme Q10 as a possible treatment for neurodegenerative diseases. Free Radic. Res. 36, 455-460. doi: 10.1080/10715760290021315
15. Ben-Meir, A., Burstein, E., Borrego-Alvarez, A., Chong, J., Wong, E., Yavorska, T., et al. (2015a). Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging. Aging Cell 14, 887-895. doi: 10.1111/acel.12368
16. Ben-Meir, A., Yahalomi, S., Moshe, B., Shufaro, Y., Reubinoff, B., and Saada, A. (2015b). Coenzyme Q-dependent mitochondrial respiratory chain activity in granulosa cells is reduced with aging. Fertil. Steril. 104, 724-727. doi: 10.1016/j.fertnstert.2015.05.023
17. Bentinger, M., Dallner, G., Choknacki, T., and Swiezewska, E. (2003). Distrinution and breakdown of labeled coenzyme Q10 in rats. Free Radic. Biol. Med. 34, 563-575. doi: 10.1016/S0891-5849(02)01357-6
18. Bentinger, M., Tekle, M., and Dallner, G. (2010). Coenzyme Q-biosynthesis and functions. Biochem. Biophys. Res. Commun. 396, 74-79. doi: 10.1016/j.bbrc.2010.02.147
19. Beyer, R. E., Burnett, B. A., Cartwright, K. J., Edington, D. W., Falzon, M. J., Kreitman, K. R., et al. (1985). Tissue coenzyme Q (ubiquinone) and protein concentrations over the life span of the laboratory rat. Mech. Ageing Dev. 32, 267-281. doi: 10.1016/0047-6374(85)90085-5
20. Bhagavan, H. N., and Chopra, R. K. (2006). Coenzyme Q10: absortion, tissue uptake, metabolism and pharmacokinetics. Free Radic. Res. 40, 445-453. doi: 10.1080/10715760600617843
21. Bolignano, D., Cernaro, V., Gembillo, G., Baggetta, R., Buemi, M., and D'arrigo, G. (2017). Antioxidant agents for delaying diabetic kidney disease progression: a systematic review and meta-analysis. PLoS ONE 12:e0178699. doi: 10.1371/journal.pone.0178699
22. Bose, A., and Beal, M. F. (2016). Mitochondrial dysfunction in Parkinson's disease. J. Neurochem. 139(Suppl. 1), 216-231. doi: 10.1111/jnc.13731
23. Brea-Calvo, G., Siendones, E., Sanchez-Alcazar, J. A., De Cabo, R., and Navas, P. (2009). Cell survival from chemotherapy depends on NF-kappaB transcriptional up-regulation of coenzyme Q biosynthesis. PLoS ONE 4:e5301. doi: 10.1371/journal.pone.0005301
24. Buhmann, C., Arlt, S., Kontush, A., Moller-Bertram, T., Sperber, S., Oechsner, M., et al. (2004). Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication. Neurobiol. Dis. 15, 160-170. doi: 10.1016/j.nbd.2003.10.003
25. Campagnolo, N., Johnston, S., Collatz, A., Staines, D., and Marshall-Gradisnik, S. (2017). Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review. J. Hum. Nutr. Diet. 30, 247-259. doi: 10.1111/jhn.12435
26. Cascajo, M. V., Abdelmohsen, K., Noh, J. H., Fernandez-Ayala, D. J., Willers, I. M., Brea, G., et al. (2016). RNA-binding proteins regulate cell respiration and coenzyme Q biosynthesis by post-transcriptional regulation of COQ7. RNA Biol. 13, 622-634. doi: 10.1080/15476286.2015.1119366
27. Crane, F. L., Low, H., Sun, I., Navas, P., and Gvozdjakova, A. (2014). Plasma membrane coenzyme Q: evidence for a role in autism. Biologics 8, 199-205. doi: 10.2147/BTT.S53375
28. De Cabo, R., Cabello, R., Rios, M., López-Lluch, G., Ingram, D. K., Lane, M. A., et al. (2004). Calorie restriction attenuates age-related alterations in the plasma membrane antioxidant system in rat liver. Exp. Gerontol. 39, 297-304. doi: 10.1016/j.exger.2003.12.003
29. de Frutos, F., Gea, A., Hernandez-Estefania, R., and Rabago, G. (2015). Prophylactic treatment with coenzyme Q10 in patients undergoing cardiac surgery: could an antioxidant reduce complications? A systematic review and meta-analysis. Interact. Cardiovasc. Thorac. Surg. 20, 254-259. doi: 10.1093/icvts/ivu334
30. Del Pozo-Cruz, J., Rodriguez-Bies, E., Ballesteros-Simarro, M., Navas-Enamorado, I., Tung, B. T., Navas, P., et al. (2014a). Physical activity affects plasma coenzyme Q10 levels differently in young and old humans. Biogerontology 15, 199-211. doi: 10.1007/s10522-013-9491-y
31. Del Pozo-Cruz, J., Rodriguez-Bies, E., Navas-Enamorado, I., Del Pozo-Cruz, B., Navas, P., and López-Lluch, G. (2014b). Relationship between functional capacity and body mass index with plasma coenzyme Q10 and oxidative damage in community-dwelling elderly-people. Exp. Gerontol. 52, 46-54. doi: 10.1016/j.exger.2014.01.026
32. Desbats, M. A., Lunardi, G., Doimo, M., Trevisson, E., and Salviati, L. (2015a). Genetic bases and clinical manifestations of coenzyme Q10 (CoQ 10) deficiency. J. Inherit. Metab. Dis. 38, 145-156. doi: 10.1007/s10545-014-9749-9
33. Desbats, M. A., Morbidoni, V., Silic-Benussi, M., Doimo, M., Ciminale, V., Cassina, M., et al. (2016). The COQ2 genotype predicts the severity of coenzyme Q10 deficiency. Hum. Mol. Genet. 25, 4256-4265. doi: 10.1093/hmg/ddw257
34. Desbats, M. A., Vetro, A., Limongelli, I., Lunardi, G., Casarin, A., Doimo, M., et al. (2015b). Primary coenzyme Q10 deficiency presenting as fatal neonatal multiorgan failure. Eur. J. Hum. Genet. 23, 1254-1258. doi: 10.1038/ejhg.2014.277
35. Doimo, M., Desbats, M. A., Cerqua, C., Cassina, M., Trevisson, E., and Salviati, L. (2014). Genetics of coenzyme q10 deficiency. Mol. Syndromol. 5, 156-162. doi: 10.1159/000362826
36. Fan, L., Feng, Y., Chen, G. C., Qin, L. Q., Fu, C. L., and Chen, L. H. (2017). Effects of coenzyme Q10 supplementation on inflammatory markers: a systematic review and meta-analysis of randomized controlled trials. Pharmacol. Res. 119, 128-136. doi: 10.1016/j.phrs.2017.01.032
37. Fedacko, J., Pella, D., Fedackova, P., Hanninen, O., Tuomainen, P., Jarcuska, P., et al. (2013). Coenzyme Q(10) and selenium in statin-associated myopathy treatment. Can. J. Physiol. Pharmacol. 91, 165-170. doi: 10.1139/cjpp-2012-0118
38. Fischer, A., Onur, S., Niklowitz, P., Menke, T., Laudes, M., Rimbach, G., et al. (2016). Coenzyme Q10 status as a determinant of muscular strength in two independent cohorts. PLoS ONE 11:e0167124. doi: 10.1371/journal.pone.0167124
39. Flowers, N., Hartley, L., Todkill, D., Stranges, S., and Rees, K. (2014). Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev. CD010405. doi: 10.1002/14651858.CD010405.pub2
40. Floyd, B. J., Wilkerson, E. M., Veling, M. T., Minogue, C. E., Xia, C., Beebe, E. T., et al. (2016). Mitochondrial protein interaction mapping identifies regulators of respiratory chain function. Mol. Cell 63, 621-632. doi: 10.1016/j.molcel.2016.06.033
41. Fotino, A. D., Thompson-Paul, A. M., and Bazzano, L. A. (2013). Effect of coenzyme Q(1)(0) supplementation on heart failure: a meta-analysis. Am. J. Clin. Nutr. 97, 268-275. doi: 10.3945/ajcn.112.040741
42. Freyer, C., Stranneheim, H., Naess, K., Mourier, A., Felser, A., Maffezzini, C., et al. (2015). Rescue of primary ubiquinone deficiency due to a novel COQ7 defect using 2,4-dihydroxybensoic acid. J. Med. Genet. 52, 779-783. doi: 10.1136/jmedgenet-2015-102986
43. Galasko, D. R., Peskind, E., Clark, C. M., Quinn, J. F., Ringman, J. M., Jicha, G. A., et al. (2012). Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Arch. Neurol. 69, 836-841. doi: 10.1001/archneurol.2012.85
44. Genova, M. L., and Lenaz, G. (2014). Functional role of mitochondrial respiratory supercomplexes. Biochim. Biophys. Acta 1837, 427-443. doi: 10.1016/j.bbabio.2013.11.002
45. Gigante, M., Diella, S., Santangelo, L., Trevisson, E., Acosta, M. J., Amatruda, M., et al. (2017). Further phenotypic heterogeneity of CoQ10 deficiency associated with steroid resistant nephrotic syndrome and novel COQ2 and COQ6 variants. Clin. Genet. 92, 224-226. doi: 10.1111/cge.12960
46. Gonzalez-Guardia, L., Yubero-Serrano, E. M., Delgado-Lista, J., Perez-Martinez, P., Garcia-Rios, A., Marin, C., et al. (2015). Effects of the Mediterranean diet supplemented with coenzyme q10 on metabolomic profiles in elderly men and women. J. Gerontol. A Biol. Sci. Med. Sci. 70, 78-84. doi: 10.1093/gerona/glu098
47. Gorman, G. S., Chinnery, P. F., Dimauro, S., Hirano, M., Koga, Y., Mcfarland, R., et al. (2016). Mitochondrial diseases. Nat. Rev. Dis. Primers 2:16080. doi: 10.1038/nrdp.2016.80
48. Grimm, A., Friedland, K., and Eckert, A. (2016). Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease. Biogerontology 17, 281-296. doi: 10.1007/s10522-015-9618-4
49. Guaras, A., Perales-Clemente, E., Calvo, E., Acin-Perez, R., Loureiro-Lopez, M., Pujol, C., et al. (2016). The CoQH2/CoQ ratio serves as a sensor of respiratory chain efficiency. Cell Rep. 15, 197-209. doi: 10.1016/j.celrep.2016.03.009
50. Guo, R., Zong, S., Wu, M., Gu, J., and Yang, M. (2017). Architecture of human mitochondrial respiratory megacomplex I2III2IV2. Cell 170, 1247 e1212-1257 e1212. doi: 10.1016/j.cell.2017.07.050
51. Gvozdjakova, A., Kucharska, J., Dubravicky, J., Mojto, V., and Singh, R. B. (2015). Coenzyme Q(1)(0), alpha-tocopherol, and oxidative stress could be important metabolic biomarkers of male infertility. Dis. Markers 2015:827941. doi: 10.1155/2015/827941
52. Gvozdjakova, A., Kucharska, J., Ostatnikova, D., Babinska, K., Nakladal, D., and Crane, F. L. (2014). Ubiquinol improves symptoms in children with autism. Oxid. Med. Cell. Longev. 2014:798957. doi: 10.1155/2014/798957
53. Hamilton, S. J., Chew, G. T., and Watts, G. F. (2009). Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients. Diabetes Care 32, 810-812. doi: 10.2337/dc08-1736
54. Hathcock, J. N., and Shao, A. (2006). Risk assessment for coenzyme Q10 (Ubiquinone). Regul. Toxicol. Pharmacol. 45, 282-288. doi: 10.1016/j.yrtph.2006.05.006
55. He, C. H., Black, D. S., Allan, C. M., Meunier, B., Rahman, S., and Clarke, C. F. (2017). Human COQ9 rescues a coq9 yeast mutant by enhancing coenzyme Q biosynthesis from 4-hydroxybenzoic acid and stabilizing the CoQ-synthome. Front. Physiol. 8:463. doi: 10.3389/fphys.2017.00463
56. He, C. H., Xie, L. X., Allan, C. M., Tran, U. C., and Clarke, C. F. (2014). Coenzyme Q supplementation or over-expression of the yeast Coq8 putative kinase stabilizes multi-subunit Coq polypeptide complexes in yeast coq null mutants. Biochim. Biophys. Acta 1841, 630-644. doi: 10.1016/j.bbalip.2013.12.017
57. Heeringa, S. F., Chernin, G., Chaki, M., Zhou, W., Sloan, A. J., Ji, Z., et al. (2011). COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J. Clin. Invest. 121, 2013-2024. doi: 10.1172/JCI45693
58. Ishikawa, A., Kawarazaki, H., Ando, K., Fujita, M., Fujita, T., and Homma, Y. (2011). Renal preservation effect of ubiquinol, the reduced form of coenzyme Q10. Clin. Exp. Nephrol. 15, 30-33. doi: 10.1007/s10157-010-0350-8
59. Ishrat, T., Khan, M. B., Hoda, M. N., Yousuf, S., Ahmad, M., Ansari, M. A., et al. (2006). Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats. Behav. Brain Res. 171, 9-16. doi: 10.1016/j.bbr.2006.03.009
60. Jakobs, B. S., Van Den Heuvel, L. P., Smeets, R. J., De Vries, M. C., Hien, S., Schaible, T., et al. (2013). A novel mutation in COQ2 leading to fatal infantile multisystem disease. J. Neurol. Sci. 326, 24-28. doi: 10.1016/j.jns.2013.01.004
61. Johansson, P., Dahlstrom, O., Dahlstrom, U., and Alehagen, U. (2015). Improved health-related quality of life, and more days out of hospital with supplementation with selenium and coenzyme Q10 combined. Results from a double blind, placebo-controlled prospective study. J. Nutr. Health Aging 19, 870-877. doi: 10.1007/s12603-015-0509-9
62. Kalen, A., Appelkvist, E. L., and Dallner, G. (1989). Age-related changes in the lipid compositions of rat and human tissues. Lipids 24, 579-584. doi: 10.1007/BF02535072
63. Kawamukai, M. (2015). Biosynthesis of coenzyme Q in eukaryotes. Biosci. Biotechnol. Biochem. 80, 23-33. doi: 10.1080/09168451.2015.1065172
64. Lafuente, R., Gonzalez-Comadran, M., Sola, I., Lopez, G., Brassesco, M., Carreras, R., et al. (2013). Coenzyme Q10 and male infertility: a meta-analysis. J. Assist. Reprod. Genet. 30, 1147-1156. doi: 10.1007/s10815-013-0047-5
65. Lapointe, J., and Hekimi, S. (2008). Early mitochondrial dysfunction in long-lived Mclk1+/-mice. J. Biol. Chem. 283, 26217-26227. doi: 10.1074/jbc.M803287200
66. Lapuente-Brun, E., Moreno-Loshuertos, R., Acin-Perez, R., Latorre-Pellicer, A., Colas, C., Balsa, E., et al. (2013). Supercomplex assembly determines electron flux in the mitochondrial electron transport chain. Science 340, 1567-1570. doi: 10.1126/science.1230381
67. Laredj, L. N., Licitra, F., and Puccio, H. M. (2014). The molecular genetics of coenzyme Q biosynthesis in health and disease. Biochimie 100, 78-87. doi: 10.1016/j.biochi.2013.12.006
68. Law, M., and Rudnicka, A. R. (2006). Statin safety: a systematic review. Am. J. Cardiol. 97, 52C-60C. doi: 10.1016/j.amjcard.2005.12.010
69. Littarru, G. P., and Langsjoen, P. (2007). Coenzyme Q10 and statins: biochemical and clinical implications. Mitochondrion 7(Suppl.), S168-S174. doi: 10.1016/j.mito.2007.03.002
70. Liu, J., and Wang, L. N. (2014). Mitochondrial enhancement for neurodegenerative movement disorders: a systematic review of trials involving creatine, coenzyme Q10, idebenone and mitoquinone. CNS Drugs 28, 63-68. doi: 10.1007/s40263-013-0124-4
71. Liu, J., Wang, L., Zhan, S. Y., and Xia, Y. (2011). Coenzyme Q10 for Parkinson's disease. Cochrane Database Syst. Rev. CD008150. doi: 10.1002/14651858.CD008150.pub2
72. López-Lluch, G., Rios, M., Lane, M. A., Navas, P., and De Cabo, R. (2005). Mouse liver plasma membrane redox system activity is altered by aging and modulated by calorie restriction. Age 27, 153-160. doi: 10.1007/s11357-005-2726-3
73. López-Lluch, G., Rodriguez-Aguilera, J. C., Santos-Ocana, C., and Navas, P. (2010). Is coenzyme Q a key factor in aging? Mech. Ageing Dev. 131, 225-235. doi: 10.1016/j.mad.2010.02.003
74. Madmani, M. E., Yusuf Solaiman, A., Tamr Agha, K., Madmani, Y., Shahrour, Y., Essali, A., et al. (2014). Coenzyme Q10 for heart failure. Cochrane Database Syst. Rev. CD008684. doi: 10.1002/14651858.CD008684.pub2
75. Martin-Montalvo, A., Gonzalez-Mariscal, I., Padilla, S., Ballesteros, M., Brautigan, D. L., Navas, P., et al. (2011). Respiratory-induced coenzyme Q biosynthesis is regulated by a phosphorylation cycle of Cat5p/Coq7p. Biochem. J. 440, 107-114. doi: 10.1042/BJ20101422
76. Martin-Montalvo, A., Gonzalez-Mariscal, I., Pomares-Viciana, T., Padilla-Lopez, S., Ballesteros, M., Vazquez-Fonseca, L., et al. (2013). The phosphatase Ptc7 induces coenzyme Q biosynthesis by activating the hydroxylase Coq7 in yeast. J. Biol. Chem. 288, 28126-28137. doi: 10.1074/jbc.M113.474494
77. Martin-Montalvo, A., Sun, Y., Diaz-Ruiz, A., Ali, A., Gutierrez, V., Palacios, H. H., et al. (2016). Cytochrome b5 reductase and the control of lipid metabolism and healthspan. NPJ Aging Mech. Dis. 2:16006. doi: 10.1038/npjamd.2016.6
78. Mazidi, M., Kengne, A. P., Banach, M., Lipid, and Blood Pressure Meta-Analysis Collaboration, G. (2017). Effects of coenzyme Q10 supplementation on plasma C-reactive protein concentrations: A systematic review and meta-analysis of randomized controlled trials. Pharmacol. Res. doi: 10.1016/j.phrs.2017.08.011. [Epub ahead of print]
79. McGarry, A., McDermott, M., Kieburtz, K., De Blieck, E. A., Beal, F., Marder, K., et al. (2017). A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology 88, 152-159. doi: 10.1212/WNL.0000000000003478
80. Milenkovic, D., Blaza, J. N., Larsson, N. G., and Hirst, J. (2017). The enigma of the respiratory chain supercomplex. Cell Metab. 25, 765-776. doi: 10.1016/j.cmet.2017.03.009
81. Mischley, L. K., Allen, J., and Bradley, R. (2012). Coenzyme Q10 deficiency in patients with Parkinson's disease. J. Neurol. Sci. 318, 72-75. doi: 10.1016/j.jns.2012.03.023
82. Molyneux, S., Florkowski, C., Lever, M., and George, P. (2004). The bioavailability of coenzyme Q10 supplements available in New Zealand differs markedly. N. Z. Med. J. 117, U1108
83. Montini, G., Malaventura, C., and Salviati, L. (2008). Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. N. Engl. J. Med. 358, 2849-2850. doi: 10.1056/NEJMc0800582
84. Moradi, M., Haghighatdoost, F., Feizi, A., Larijani, B., and Azadbakht, L. (2016). Effect of coenzyme Q10 supplementation on diabetes biomarkers: a systematic review and meta-analysis of randomized controlled clinical trials. Arch. Iran. Med. 19, 588-596
85. Morgenstern, M., Stiller, S. B., Lubbert, P., Peikert, C. D., Dannenmaier, S., Drepper, F., et al. (2017). Definition of a high-confidence mitochondrial proteome at quantitative scale. Cell Rep. 19, 2836-2852. doi: 10.1016/j.celrep.2017.06.014
86. Mortensen, S. A., Rosenfeldt, F., Kumar, A., Dolliner, P., Filipiak, K. J., Pella, D., et al. (2014). The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 2, 641-649. doi: 10.1016/j.jchf.2014.06.008
87. Navas, P., Villalba, J. M., and De Cabo, R. (2007). The importance of plasma membrane coenzyme Q in aging and stress responses. Mitochondrion 7(Suppl.), S34-S40. doi: 10.1016/j.mito.2007.02.010
88. Negida, A., Menshawy, A., El Ashal, G., Elfouly, Y., Hani, Y., Hegazy, Y., et al. (2016). Coenzyme Q10 for patients with parkinson's disease: a systematic review and meta-analysis. CNS Neurol. Disord. Drug Targets 15, 45-53. doi: 10.2174/1871527314666150821103306
89. Perez-Sanchez, C., Aguirre, M. A., Ruiz-Limon, P., Abalos-Aguilera, M. C., Jimenez-Gomez, Y., Arias-De La Rosa, I., et al. (2017). Ubiquinol effects on antiphospholipid syndrome prothrombotic profile: a randomized, placebo-controlled trial. Arterioscler. Thromb. Vasc. Biol. 37, 1923-1932. doi: 10.1161/ATVBAHA.117.309225
90. Pineda, M., Montero, R., Aracil, A., O'callaghan, M. M., Mas, A., Espinos, C., et al. (2010). Coenzyme Q(10)-responsive ataxia: 2-year-treatment follow-up. Mov. Disord. 25, 1262-1268. doi: 10.1002/mds.23129
91. Pirro, M., Mannarino, M. R., Bianconi, V., Simental-Mendia, L. E., Bagaglia, F., Mannarino, E., et al. (2016). The effects of a nutraceutical combination on plasma lipids and glucose: a systematic review and meta-analysis of randomized controlled trials. Pharmacol. Res. 110, 76-88. doi: 10.1016/j.phrs.2016.04.021
92. Rivara, M. B., Yeung, C. K., Robinson-Cohen, C., Phillips, B. R., Ruzinski, J., Rock, D., et al. (2017). Effect of coenzyme Q10 on biomarkers of oxidative stress and cardiac function in hemodialysis patients: the CoQ10 biomarker trial. Am. J. Kidney Dis. 69, 389-399. doi: 10.1053/j.ajkd.2016.08.041
93. Rodriguez-Aguilera, J. C., Cortes, A. B., Fernandez-Ayala, D. J., and Navas, P. (2017). Biochemical assessment of coenzyme Q10 deficiency. J. Clin. Med. 6:E27. doi: 10.3390/jcm6030027
94. Ross, D., and Siegel, D. (2017). Functions of NQO1 in cellular protection and CoQ10 metabolism and its potential role as a redox sensitive molecular switch. Front. Physiol. 8:595. doi: 10.3389/fphys.2017.00595
95. Rossignol, D. A., and Frye, R. E. (2012). Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol. Psychiatry 17, 290-314. doi: 10.1038/mp.2010.136
96. Safarinejad, M. R., Safarinejad, S., Shafiei, N., and Safarinejad, S. (2012). Effects of the reduced form of coenzyme Q10 (ubiquinol) on semen parameters in men with idiopathic infertility: a double-blind, placebo controlled, randomized study. J. Urol. 188, 526-531. doi: 10.1016/j.juro.2012.03.131
97. Sahebkar, A., Simental-Mendia, L. E., Stefanutti, C., and Pirro, M. (2016). Supplementation with coenzyme Q10 reduces plasma lipoprotein(a) concentrations but not other lipid indices: a systematic review and meta-analysis. Pharmacol. Res. 105, 198-209. doi: 10.1016/j.phrs.2016.01.030
98. Saiki, R., Lunceford, A. L., Shi, Y., Marbois, B., King, R., Pachuski, J., et al. (2008). Coenzyme Q10 supplementation rescues renal disease in Pdss2kd/kd mice with mutations in prenyl diphosphate synthase subunit 2. Am. J. Physiol. Renal Physiol. 295, F1535-F1544. doi: 10.1152/ajprenal.90445.2008
99. Salviati, L., Trevisson, E., Doimo, M., and Navas, P. (2017). "Primary Coenzyme Q10 Deficiency," in GeneReviews(R), eds R. A. Pagon, M. P. Adam, H. H. Ardinger, S. E. Wallace, A. Amemiya, L. J. H. Bean, et al. (Seattle, WA: University of Washington)
100. Salviati, L., Trevisson, E., Rodriguez Hernandez, M. A., Casarin, A., Pertegato, V., Doimo, M., et al. (2012). Haploinsufficiency of COQ4 causes coenzyme Q10 deficiency. J. Med. Genet. 49, 187-191. doi: 10.1136/jmedgenet-2011-100394
101. Santos-Ocana, C., Do, T. Q., Padilla, S., Navas, P., and Clarke, C. F. (2002). Uptake of exogenous coenzyme Q and transport to mitochondria is required for bc1 complex stability in yeast coq mutants. J. Biol. Chem. 277, 10973-10981. doi: 10.1074/jbc.M112222200
102. Schirris, T. J., Renkema, G. H., Ritschel, T., Voermans, N. C., Bilos, A., Van Engelen, B. G., et al. (2015). Statin-induced myopathy is associated with mitochondrial complex III inhibition. Cell Metab. 22, 399-407. doi: 10.1016/j.cmet.2015.08.002
103. Schmelzer, C., Kubo, H., Mori, M., Sawashita, J., Kitano, M., Hosoe, K., et al. (2010). Supplementation with the reduced form of Coenzyme Q10 decelerates phenotypic characteristics of senescence and induces a peroxisome proliferator-activated receptor-alpha gene expression signature in SAMP1 mice. Mol. Nutr. Food Res. 54, 805-815. doi: 10.1002/mnfr.200900155
104. Schulz, J. B., and Beal, M. F. (1995). Neuroprotective effects of free radical scavengers and energy repletion in animal models of neurodegenerative disease. Ann. N. Y. Acad. Sci. 765, 100-110. discussion: 116-108. doi: 10.1111/j.1749-6632.1995.tb16565.x
105. Scialo, F., Sriram, A., Fernandez-Ayala, D., Gubina, N., Lohmus, M., Nelson, G., et al. (2016). Mitochondrial ROS produced via reverse electron transport extend animal lifespan. Cell Metab. 23, 725-734. doi: 10.1016/j.cmet.2016.03.009
106. Shults, C. W. (2003). Coenzyme Q10 in neurodegenerative diseases. Curr. Med. Chem. 10, 1917-1921. doi: 10.2174/0929867033456882
107. Silver, M. A., Langsjoen, P. H., Szabo, S., Patil, H., and Zelinger, A. (2004). Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction. Am. J. Cardiol. 94, 1306-1310. doi: 10.1016/j.amjcard.2004.07.121
108. Sondheimer, N., Hewson, S., Cameron, J. M., Somers, G. R., Broadbent, J. D., Ziosi, M., et al. (2017). Novel recessive mutations in COQ4 cause severe infantile cardiomyopathy and encephalopathy associated with CoQ10 deficiency. Mol. Genet. Metab. Rep. 12, 23-27. doi: 10.1016/j.ymgmr.2017.05.001
109. Suksomboon, N., Poolsup, N., and Juanak, N. (2015). Effects of coenzyme Q10 supplementation on metabolic profile in diabetes: a systematic review and meta-analysis. J. Clin. Pharm. Ther. 40, 413-418. doi: 10.1111/jcpt.12280
110. Thomas, S. R., Neuzil, J., and Stocker, R. (1997). Inhibition of LDL oxidation by ubiquinol-10. A protective mechanism for coenzyme Q in atherogenesis? Mol. Aspects Med. 18(Suppl.), S85-S103
111. Thompson, P. D., Clarkson, P., and Karas, R. H. (2003). Statin-associated myopathy. JAMA 289, 1681-1690. doi: 10.1001/jama.289.13.1681
112. Tian, G., Sawashita, J., Kubo, H., Nishio, S. Y., Hashimoto, S., Suzuki, N., et al. (2014). Ubiquinol-10 supplementation activates mitochondria functions to decelerate senescence in senescence-accelerated mice. Antioxid. Redox Signal. 20, 2606-2620. doi: 10.1089/ars.2013.5406
113. Tiano, L., and Busciglio, J. (2011). Mitochondrial dysfunction and Down's syndrome: is there a role for coenzyme Q(10) γ Biofactors 37, 386-392. doi: 10.1002/biof.184
114. Tiano, L., Carnevali, P., Padella, L., Santoro, L., Principi, F., Bruge, F., et al. (2011). Effect of coenzyme Q10 in mitigating oxidative DNA damage in Down syndrome patients, a double blind randomized controlled trial. Neurobiol. Aging 32, 2103-2105. doi: 10.1016/j.neurobiolaging.2009.11.016
115. Tocilescu, M. A., Zickermann, V., Zwicker, K., and Brandt, U. (2010). Quinone binding and reduction by respiratory complex I. Biochim. Biophys. Acta 1797, 1883-1890. doi: 10.1016/j.bbabio.2010.05.009
116. Trevisson, E., Dimauro, S., Navas, P., and Salviati, L. (2011). Coenzyme Q deficiency in muscle. Curr. Opin. Neurol. 24, 449-456. doi: 10.1097/WCO.0b013e32834ab528
117. Turunen, M., Appelkvist, E. L., Sindelar, P., and Dallner, G. (1999). Blood concentration of coenzyme Q(10) increases in rats when esterified forms are administered. J. Nutr. 129, 2113-2118
118. Turunen, M., Peters, J. M., Gonzalez, F. J., Schedin, S., and Dallner, G. (2000). Influence of peroxisome proliferator-activated receptor alpha on ubiquinone biosynthesis. J. Mol. Biol. 297, 607-614. doi: 10.1006/jmbi.2000.3596
119. Varela-Lopez, A., Giampieri, F., Battino, M., and Quiles, J. L. (2016). Coenzyme Q and its role in the dietary therapy against aging. Molecules 21:373. doi: 10.3390/molecules21030373
120. Weis, M., Mortensen, S. A., Rassing, M. R., Moller-Sonnergaard, J., Poulsen, G., and Rasmussen, S. N. (1994). Bioavailability of four oral coenzyme Q10 formulations in healthy volunteers. Mol. Aspects Med. 15(Suppl.), s273-s280
121. Wilcock, D. M., and Griffin, W. S. (2013). Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis. J. Neuroinflammation 10:84. doi: 10.1186/1742-2094-10-84
122. Young, J. M., Florkowski, C. M., Molyneux, S. L., Mcewan, R. G., Frampton, C. M., George, P. M., et al. (2007). Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia. Am. J. Cardiol. 100, 1400-1403. doi: 10.1016/j.amjcard.2007.06.030
123. Yubero, D., Montero, R., Martin, M. A., Montoya, J., Ribes, A., Grazina, M., et al. (2016). Secondary coenzyme Q10 deficiencies in oxidative phosphorylation (OXPHOS) and non-OXPHOS disorders. Mitochondrion 30, 51-58. doi: 10.1016/j.mito.2016.06.007
124. Yubero, D., O'callaghan, M., Montero, R., Ormazabal, A., Armstrong, J., Espinos, C., et al. (2014). Association between coenzyme Q10 and glucose transporter (GLUT1) deficiency. BMC Pediatr. 14:284. doi: 10.1186/s12887-014-0284-5
125. Zaki, M. E., El-Bassyouni, H. T., Tosson, A. M., Youness, E., and Hussein, J. (2017). Coenzyme Q10 and pro-inflammatory markers in children with Down syndrome: clinical and biochemical aspects. J. Pediatr). 93, 100-104. doi: 10.1016/j.jped.2016.04.012
126. Zhai, J., Bo, Y., Lu, Y., Liu, C., and Zhang, L. (2017). Effects of coenzyme Q10 on markers of inflammation: a systematic review and meta-analysis. PLoS ONE 12:e0170172. doi: 10.1371/journal.pone.0170172